Get all your news in one place.

100's of premium titles.
One app.

Get all your news in one place.

100's of premium titles. One news app.

The Latest Breaking News from CVS Health

Check Out What Whales Are Doing With CVS

Someone with a lot of money to spend has taken a bearish stance on CVS Health (NYSE:CVS). And retail traders should know. We noticed this today when the big position showed up on publicly available options history that we track here at Benzinga.

Benzinga

CVS Health Q1 Earnings Beat Street Expectations, Raises FY22 Adjusted EPS Forecast

CVS Health Corp's (NYSE:CVS) Q1 sales increased 11.2% Y/Y to $76.83 billion, beating the consensus of $75.39 billion. Adjusted operating income increased 6.6% to $4.48 billion primarily due to increased prescription and front store volume, including the sale of COVID-19 OTC test kits and the impact of COVID-19 vaccinations in the Retail/LTC…

Benzinga

CVS Health: Q1 Earnings Insights

CVS Health (NYSE:CVS) reported its Q1 earnings results on Wednesday, May 4, 2022 at 06:30 AM. Here's what investors need to know about the announcement.

Benzinga

From analysis to the latest developments in health,
read the most diverse news in one place.

How Markets Are Playing CVS Health, T-Mobile US

On CNBC's "Options Action," Carter Worth said CVS Health Corp (NYSE: CVS) “acts poorly going into earnings.” He added, “If you’re long, we’ll take measures.

Benzinga

$100 Invested In CVS Health 20 Years Ago Would Be Worth This Much

CVS Health (NYSE:CVS) has outperformed the market over the past 20 years by 2.04% on an annualized basis producing an average annual return of 9.11%. Currently, CVS Health has a market capitalization of $126.21 billion.

Benzinga

Here's How Much $1000 Invested In CVS Health 20 Years Ago Would Be Worth Today

CVS Health (NYSE:CVS) has outperformed the market over the past 20 years by 2.37% on an annualized basis producing an average annual return of 9.55%. Currently, CVS Health has a market capitalization of $135.84 billion.

Benzinga

CVS Health Whale Trades Spotted

A whale with a lot of money to spend has taken a noticeably bullish stance on CVS Health. Looking at options history for CVS Health (NYSE:CVS) we detected 14 strange trades.

Benzinga

Read news from The Economist, FT, and more,
with one subscription

Looking At CVS Health's Recent Whale Trades

A whale with a lot of money to spend has taken a noticeably bullish stance on CVS Health. Looking at options history for CVS Health (NYSE:CVS) we detected 10 strange trades.

Benzinga

CVS Health Whale Trades Spotted

A whale with a lot of money to spend has taken a noticeably bullish stance on CVS Health. Looking at options history for CVS Health (NYSE:CVS) we detected 15 strange trades.

Benzinga

Here's How Much You Would Have Made Owning CVS Health Stock In The Last 20 Years

CVS Health (NYSE:CVS) has outperformed the market over the past 20 years by 2.25% on an annualized basis producing an average annual return of 9.56%. Currently, CVS Health has a market capitalization of $137.41 billion.

Benzinga

Benzinga's Top Ratings Upgrades, Downgrades For March 29, 2022

Upgrades

Benzinga

Walmart to stub out cigarette sales in some stores

Walmart is not the first national retail chain to cut off cigarette sales even on a trial basis, but it is the largest.

Chicago Sun-Times

3 Rock-Solid Stocks to Strengthen Your Portfolio

The stock market has been volatile lately amid investors’ anticipation of Federal Reserve interest rate hikes, skyrocketing inflation, supply chain disruptions, and a war between Russia and Ukraine. However, investing in companies with strong fundamentals and impressive growth prospects could help hedge market risks. So, we think it could be…

StockNews.com

Here's How Much You Would Have Made Owning CVS Health Stock In The Last 20 Years

CVS Health (NYSE:CVS) has outperformed the market over the past 20 years by 2.61% on an annualized basis.

Benzinga

Get all your
news in one place.

100's of premium titles.
One news app.

Benzinga

CVS Health Whale Trades For March 15

Axios

The health worker shortage is starting to get real for Americans

More than half of all Americans say they've directly felt the effects of health care worker shortages, from canceled appointments to delayed surgeries, according to results from a CVS Health-Harris Poll National Health project provided to Axios.

Benzinga

Analyst Ratings For CVS Health

Within the last quarter, CVS Health (NYSE:CVS) has observed the following analyst ratings:

Benzinga

Is Now The Time To Buy Stock In DiDi Global, Affirm, Zoom Or CVS Health?

One of the most common questions traders have about stocks is “Why Is It Moving?”

Get all your
news in one place.

100's of premium titles.
One news app.

Benzinga

$100 Invested In This Stock 20 Years Ago, Would Be Worth This Much

CVS Health (NYSE:CVS) has outperformed the market over the past 20 years by 3.35% on an annualized basis.

Benzinga

CVS Health Earnings Perspective: Return On Invested Capital

According to Benzinga Pro data CVS Health (NYSE:CVS) posted a 18.34% decrease in earnings from Q3. Sales, however, increased by 3.81% over the previous quarter to $76.60 billion.

Benzinga

CVS Health: Q4 Earnings Insights

CVS Health (NYSE:CVS) reported its Q4 earnings results on Wednesday, February 9, 2022 at 06:30 AM. Here's what investors need to know about the announcement.

Benzinga

CVS Health Fourth Quarter Performance Gets A Boost From COVID-19 Vaccinations, Reaffirms FY22 Outlook

CVS Health Corporation's (NYSE: CVS)

Benzinga

What Are Whales Doing With CVS Health

Fortune

Karen Lynch got the big job at CVS. Now comes the big challenge: Vaccinate America

The new CVS Health chief is the highest-ranking female CEO ever to appear in the Fortune 500—just in time for the company’s most important mission yet.

1 … 5 6 7 8

People

Mangeet Kaur BounsMangeet

From analysis to the latest developments in health,
read the most diverse news in one place.

Organisations

Read news from The Economist, FT, and more,
with one subscription

Topics

Places

Fourteen days free

Download the app

One app. One membership.
100+ trusted global sources.